Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed A Eldeeb

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|August 21, 2020
N-Terminal-Dependent Protein Degradation and Targeting Cancer CellsMohamed A Eldeeb
Molecular Biology Reports|July 28, 2022
A molecular dialogue between local translation and mitochondria: powering mitophagy in axonsAndrea Soumbasis, Mohamed A Eldeeb
Anti-Cancer Agents in Medicinal Chemistry|January 10, 2025
N-Degron PROTACs as a Potential Therapeutic Approach for Chronic Myeloid LeukemiaGrace Hohman, Mohamed A Eldeeb
Neural Regeneration Research|April 14, 2026
Potential role of cytosolic PTEN-induced kinase 1 in facilitating proteaphagyGrace Hohman, Mohamed A Eldeeb
Current Genetics|March 12, 2020
N-degron-mediated degradation and regulation of mitochondrial PINK1 kinaseMohamed A Eldeeb, Mohamed A Ragheb
Current Protein & Peptide Science|August 10, 2018
Post-translational N-terminal Arginylation of Protein Fragments: A Pivotal Portal to ProteolysisMohamed A Eldeeb, Mohamed A Ragheb
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2026
Emerging pharmacology of targeted protein degradersSamir H Barghout, Mohamed A Eldeeb
Oncotarget|May 7, 2014
The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathwayMohamed A Eldeeb, Richard P Fahlman
Trends in Biochemical Sciences|May 24, 2018
Does Too Much MAGIC Lead to Mitophagy?Mohamed A Eldeeb, Richard P Fahlman
The Journal of Biological Chemistry|September 8, 2016
Phosphorylation Impacts N-end Rule Degradation of the Proteolytically Activated Form of BMX KinaseMohamed A Eldeeb, Richard P Fahlman
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Anti-Cancer Agents in Medicinal Chemistry|August 21, 2020
N-Terminal-Dependent Protein Degradation and Targeting Cancer CellsMohamed A Eldeeb
Molecular Biology Reports|July 28, 2022
A molecular dialogue between local translation and mitochondria: powering mitophagy in axonsAndrea Soumbasis, Mohamed A Eldeeb
Anti-Cancer Agents in Medicinal Chemistry|January 10, 2025
N-Degron PROTACs as a Potential Therapeutic Approach for Chronic Myeloid LeukemiaGrace Hohman, Mohamed A Eldeeb
Neural Regeneration Research|April 14, 2026
Potential role of cytosolic PTEN-induced kinase 1 in facilitating proteaphagyGrace Hohman, Mohamed A Eldeeb
Current Genetics|March 12, 2020
N-degron-mediated degradation and regulation of mitochondrial PINK1 kinaseMohamed A Eldeeb, Mohamed A Ragheb
Current Protein & Peptide Science|August 10, 2018
Post-translational N-terminal Arginylation of Protein Fragments: A Pivotal Portal to ProteolysisMohamed A Eldeeb, Mohamed A Ragheb
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2026
Emerging pharmacology of targeted protein degradersSamir H Barghout, Mohamed A Eldeeb
Oncotarget|May 7, 2014
The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathwayMohamed A Eldeeb, Richard P Fahlman
Trends in Biochemical Sciences|May 24, 2018
Does Too Much MAGIC Lead to Mitophagy?Mohamed A Eldeeb, Richard P Fahlman
The Journal of Biological Chemistry|September 8, 2016
Phosphorylation Impacts N-end Rule Degradation of the Proteolytically Activated Form of BMX KinaseMohamed A Eldeeb, Richard P Fahlman
Pageof 5